Baxter International, Inc. (BAX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Baxter International, Inc. (“Baxter” or the “Company”) (
NYSE: BAX) investors concerning the Company’s possible violations of federal securities laws.
BAX INVESTORS: Kirby McInerney LLP Reminds Baxter International, Inc. Investors of Important Deadline in Class Action Lawsuit
If you have suffered a loss on your Baxter International, Inc. (“Baxter” or the “Company”) (
NYSE:BAX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Baxter International, Inc. (“Baxter” or the “Company”) (
NYSE: BAX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against Baxter International, Inc. (BAX)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against Baxter International, Inc. (BAX)NEW YORK - October 22, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. (
NYSE: BAX) of a class action securities lawsuit.
BAXTER INTERNATIONAL INC. (NYSE: BAX) INVESTOR ALERT Investors With Large Losses in Baxter International Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Baxter International Inc. (“Baxter” or the “Company”) (
NYSE: BAX) between February 23, 2022 and July 30, 2025, inclusive.
BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (
NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., No. 25-cv-12672 (N.D. Ill.), the Baxter class action lawsuit charges Baxter and certain of Baxter’s top current and former executives with violations of the Securities Exchange Act of 1934.
BAX Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Filed Against Baxter International, Inc.SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Baxter International, Inc. (
NYSE: BAX) common stock between February 23, 2022 and July 30, 2025. Baxter is a global company that develops, manufactures, and markets medical products used in hospitals and other healthcare facilities.
Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX
The DJS Law Group reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (
NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Kirby McInerney LLP Reminds Baxter International, Inc. Investors of Class Action Filing and Encourages Investors to Contact the FirmNEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Baxter International, Inc. (“Baxter” or the “Company”) (
NYSE:BAX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Rosen Law Firm Urges Baxter International Inc. (NYSE: BAX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Baxter International Inc. (
NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”). Baxter develops, manufactures, and markets medical products.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (
NYSE: BAX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (
NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Labaton Keller Sucharow LLP Files Securities Class Action Against Baxter International, Inc. and Certain of Its Executives
Labaton Keller Sucharow LLP (“Labaton”) has filed a securities class action lawsuit (the “Action”) on behalf of its client the Electrical Workers Pension Fund, Local 103, I.B.E.W. (“Local 103”) against Baxter International, Inc. (“Baxter” or the “Company”) (
NYSE: BAX) and certain of its executives (collectively, “Defendants”). The Action, which is captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., No. 25-cv-12672 (N.D. Ill.), asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder, on behalf of all persons and entities that purchased or otherwise acquired Baxter common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors
Baxter International Inc. (
NYSE:BAX), a leading global medtech company, will host a conference call to discuss its third-quarter 2025 financial results on Thursday, October 30, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156235 to pre-register for the call and receive the call information.
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC)
Baxter International Inc. (
NYSE:BAX), a leading global medtech company, today announced that it has been awarded a Gold Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC) in the categories of IV Solutions, Nutrition Solutions and Premix Drugs. Baxter is the first manufacturer to earn this distinction across these categories, underscoring Baxter’s commitment to building a stronger, more reliable supply chain.
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
Baxter International Inc. (
NYSE:BAX), a leading global medtech company, today launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter’s connected monitoring portfolio, Connex 360 offers an advanced connectivity and security platform, customizable configurations based on a hospital’s clinical routines, and upgrade capabilities that set the stage for future functionality and enhancements. With automated clinical documentation, Connex 360 is designed to simplify the clinician experience and allow more time to focus on patients.
